Cancer Therapy News and Research

RSS

Researchers develop novel mouse model to study immunomodulatory therapies

Because mice do not respond to immunomodulatory drugs, preclinical therapeutic and safety studies of the effects of IMiDs have not been possible in existing types of mice.

19 Nov 2018

Personalized scheduling of radiotherapy using genetic data could reduce side effects

A new clinical study led by the University of Leicester and conducted in the HOPE clinical trials facility at Leicester's Hospitals has revealed the pivotal role that changing the time of day that a patient receives radiotherapy could play in altering radiotherapy toxicity.

16 Nov 2018

NIH awards over $1.8 million to husband-and-wife doctors to test new breast cancer approach

Husband-and-wife doctors at the University of Virginia Cancer Center have been awarded more than $1.8 million from the National Institutes of Health for their effort to improve radiation therapy and breast surgery for patients with early-stage breast cancer.

16 Nov 2018

Specific bacterial toxins reduce number of cells suppressing immune response

Staphylococcus aureus bacteria can cause numerous diseases, such as skin infections, pneumonia and blood poisoning.

16 Nov 2018

Two genomic tests help identify most effective treatment for breast cancer patients

New results from a long-running trial to identify which new drugs or combinations of drugs are most effective in which types of breast cancer, show that two genomic tests are bringing the era of truly personalized medicine ever nearer.

14 Nov 2018

Survey: Majority of Americans are concerned about health threat posed by antibiotic resistance

Nearly two thirds of Americans (65%) say antibiotic resistance is a public health problem and a strong majority (81%) say they are concerned that antibiotic resistance will make more infections difficult or impossible to treat and even deadly, according to a national public opinion survey commissioned by Research!America in collaboration with the Infectious Disease Society of America.

13 Nov 2018

Study shows novel strategy to reduce breast cancer bone metastasis

Uncovering a novel mechanism that promotes growth of breast cancer bone metastasis has revealed a potential Achilles' heel for these cancer cells. Reported in the journal Cancer Cell, the study shows that interfering with this mechanism can reduce the risk of relapses in animal models.

12 Nov 2018

Scientists develop new method to produce irradiated nanomaterials for medical applications

Under the leadership of Petr Cígler from the Institute of Organic Chemistry and Biochemistry and Martin Hrubý from the Institute of Macromolecular Chemistry, both of which are part of the Czech Academy of Sciences, a team of researchers has developed a revolutionary method for the easy and inexpensive production of irradiated nanodiamonds and other nanomaterials suitable for use in highly sensitive diagnostics of diseases, including various types of cancer.

12 Nov 2018

Grants aim to provide better cancer clinical trial access for military veterans

For the fourth year, SWOG Cancer Research Network and its charity, The Hope Foundation for Cancer Research, are giving military veterans better access to cancer clinical trials by providing grant support to U.S. Department of Veterans Affairs medical centers.

9 Nov 2018

CDK2 protein plays key role in heart damage caused by doxorubicin, finds study

A new study by Washington State University researchers suggests that a protein called CDK2 plays a critical role in heart damage caused by doxorubicin, a commonly used chemotherapy drug.

8 Nov 2018

New open source decision support tool could help clinicians chose chemotherapy drugs

The selection of a first-line chemotherapy drug to treat many types of cancer is often a clear-cut decision governed by standard-of-care protocols, but what drug should be used next if the first one fails?

8 Nov 2018

Mutant p53 protein 'tackles' DNA guardian to drive tumor development

Melbourne scientists have discovered how tumor development is driven by mutations in the most important gene in preventing cancer, p53.

7 Nov 2018

Treating pre-cancerous stem cells at early stage could be key to preventing bowel cancer

Treating pre-cancerous stem cells at an early stage could be key to preventing bowel cancer in people born with a very high risk of the disease, according to a study in mice presented at the 2018 NCRI Cancer Conference.

7 Nov 2018

WPI professor explores how lipids in our bodies and cell membranes affect aging, long-term health

A professor at Worcester Polytechnic Institute is exploring aging on the molecular level, examining how the lipids found in our bodies, particularly those in our cell membranes, change as we age, and how those changes may affect bone and muscle strength, brain health, and our propensity for age-related diseases, including Alzheimer's disease.

7 Nov 2018

New synthetic compound based on brain hormone holds promise for cancer treatment

A lab team led by Nobel Prize winner Dr. Andrew Schally at the Miami Veterans Affairs Healthcare System and the University of Miami showed that a synthetic compound based on a brain hormone spurred the growth of cancer cells in Petri dishes but enigmatically had the opposite effect in mice.

6 Nov 2018

TGen and City of Hope announce letter of intent to develop new cell therapy manufacturing facility

City of Hope, a world-renowned independent cancer research and treatment center, and its affiliate, Translational Genomics Research Institute, have announced a letter of intent to develop a state-of-the-art cell therapy manufacturing facility in the Phoenix Metropolitan Area, a move that would improve the speed at which stem cell research and cancer treatment is delivered.

5 Nov 2018

TGen, City of Hope to develop cell therapy manufacturing facility in Phoenix

City of Hope, a world-renowned independent cancer research and treatment center, and its affiliate, Translational Genomics Research Institute (TGen), have announced a letter of intent to develop a state-of-the-art cell therapy manufacturing facility in the Phoenix Metropolitan Area, a move that would improve the speed at which stem cell research and cancer treatment is delivered.

2 Nov 2018

Researchers find a class of drug that could be promising treatment for uveitis

Ocular inflammation uveitis is a serious disease that can destroy eye tissue and cause irreversible blindness.

2 Nov 2018

Measles can be deadly for people with weakened immune systems

Last year, a 26-year-old man receiving treatment for leukemia went to a Swiss hospital's emergency room with a fever, a sore throat, and a cough, and was admitted. His condition worsened, and 17 days later, he died from severe complications of measles.

1 Nov 2018

MCG selected as designated laboratory for NCI-MATCH trial

The Georgia Esoteric and Molecular Laboratory at the Medical College of Georgia at Augusta University has been selected as a designated laboratory for the National Cancer Institute's Molecular Analysis for Therapy Choice, or MATCH trial, which is assessing the effectiveness of targeting cancer-causing gene changes rather than cancer type.

1 Nov 2018

Cancer Therapy News and Research

Researchers develop novel mouse model to study immunomodulatory therapies

Personalized scheduling of radiotherapy using genetic data could reduce side effects

NIH awards over $1.8 million to husband-and-wife doctors to test new breast cancer approach

Specific bacterial toxins reduce number of cells suppressing immune response

Two genomic tests help identify most effective treatment for breast cancer patients

Survey: Majority of Americans are concerned about health threat posed by antibiotic resistance

Study shows novel strategy to reduce breast cancer bone metastasis

Scientists develop new method to produce irradiated nanomaterials for medical applications

Grants aim to provide better cancer clinical trial access for military veterans

CDK2 protein plays key role in heart damage caused by doxorubicin, finds study

New open source decision support tool could help clinicians chose chemotherapy drugs

Mutant p53 protein 'tackles' DNA guardian to drive tumor development

Treating pre-cancerous stem cells at early stage could be key to preventing bowel cancer

WPI professor explores how lipids in our bodies and cell membranes affect aging, long-term health

New synthetic compound based on brain hormone holds promise for cancer treatment

TGen and City of Hope announce letter of intent to develop new cell therapy manufacturing facility

TGen, City of Hope to develop cell therapy manufacturing facility in Phoenix

Researchers find a class of drug that could be promising treatment for uveitis

Measles can be deadly for people with weakened immune systems

MCG selected as designated laboratory for NCI-MATCH trial

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News